Amin Makarem

Stock Analyst at Jefferies

(2.04)
# 3,199
Out of 4,504 analysts
2
Total ratings
100%
Success rate
47.5%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $38.56
Upside: +3.73%
Foghorn Therapeutics
Feb 16, 2026
Maintained: Buy
Price Target: $12
Current: $5.95
Upside: +101.68%